These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 332158)

  • 21. Mutagenicity of aflatoxin B1, activated by S-9 fractions of human, rat, mouse, rabbit, and monkey liver, towards S. typhimurium TA 98.
    Norpoth K; Grossmeier R; Bösenberg H; Themann H; Fleischer M
    Int Arch Occup Environ Health; 1979 Jan; 42(3-4):333-9. PubMed ID: 106015
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative mutagenicity of aflatoxins using a Salmonella/trout hepatic enzyme activation system.
    Coulombe RA; Shelton DW; Sinnhuber RO; Nixon JE
    Carcinogenesis; 1982; 3(11):1261-4. PubMed ID: 6758974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aflatoxin B1 mutagenesis, DNA binding, and adduct formation in Salmonella typhimurium.
    Stark AA; Essigmann JM; Demain AL; Skopek TR; Wogan GN
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1343-7. PubMed ID: 375236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enhancement of the effect of aflatoxin B1 by metabolic activation with rat-liver microsomes on human lymphocytes assayed with the micronucleus test.
    Iskandar O; Vijayalaxmi
    Mutat Res; 1981 Jan; 91(1):63-6. PubMed ID: 7207495
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate.
    Bodine AB; Luer CA; Gangjee S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):255-7. PubMed ID: 2866897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promutagen activation in parasite-infected organisms: preliminary observations with Fasciola hepatica-infected mice and aflatoxin B1.
    Gentile JM; DeRuiter E
    Toxicol Lett; 1981; 8(4-5):273-82. PubMed ID: 6791314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of aflatoxin B1 by using the synergistic effect of hydrogen peroxide and gamma radiation.
    Patel UD; Govindarajan P; Dave PJ
    Appl Environ Microbiol; 1989 Feb; 55(2):465-7. PubMed ID: 2497710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of mutations in DNA-repair deficient bacteria by a liver microsomal metabolite of aflatoxin B1.
    Garner RC; Wright CM
    Br J Cancer; 1973 Dec; 28(6):544-51. PubMed ID: 4593223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifying role of dietary factors on the mutagenicity of aflatoxin B1: in vitro effect of vitamins.
    Bhattacharya RK; Francis AR; Shetty TK
    Mutat Res; 1987 Jun; 188(2):121-8. PubMed ID: 3108659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of mutagenicity to Salmonella typhimurium of some Fusarium mycotoxins.
    Wehner FC; Marasas WF; Thiel PG
    Appl Environ Microbiol; 1978 Apr; 35(4):659-62. PubMed ID: 348106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
    Lake BG; Rowland IR; Harris RA; Collins MA; Phillips JC; Cottrell RC; Gangolli SD
    Adv Exp Med Biol; 1981; 136 Pt B():1143-7. PubMed ID: 6283820
    [No Abstract]   [Full Text] [Related]  

  • 32. Formation of a factor lethal for S. typhimurium TA1530 and TA1531 on incubation of aflatoxin B 1 with rat liver microsomes.
    Garner RC; Miller EC; Miller JA; Garner JV; Hanson RS
    Biochem Biophys Res Commun; 1971 Nov; 45(3):774-80. PubMed ID: 4399636
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-aflatoxin mutagenic factors in corn.
    Weng CY; Martinez AJ; Park DL
    Food Addit Contam; 1997 Apr; 14(3):269-79. PubMed ID: 9135724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation and mutation induction in bacteria by microsomal metabolites.
    Garner RC
    Biochem Soc Trans; 1975; 3(1):65-9. PubMed ID: 1092573
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutagenicity of five cyclic N-nitrosamines: assay with Salmonella typhimurium.
    Stoltz DR; Sen NP
    J Natl Cancer Inst; 1977 Feb; 58(2):393-4. PubMed ID: 319245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fate of epoxides.
    Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():39-52. PubMed ID: 7046377
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition by specific antibodies of the mutagenicity of aflatoxin B1 in bacteria.
    Sizaret P; Malaveille C; Brun G; Aguelon AM; Toussaint G
    Oncodev Biol Med; 1982; 3(2-3):125-34. PubMed ID: 6812028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The biochemical activity of the aflatoxins (author's transl)].
    Reiss J
    Zentralbl Bakteriol B; 1978 Dec; 167(5-6):435-42. PubMed ID: 373323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rationale for the non-mutagenicity of 2- and 3-aminobiphenyls.
    Ioannides C; Lewis DF; Trinick J; Neville S; Sertkaya NN; Kajbaf M; Gorrod JW
    Carcinogenesis; 1989 Aug; 10(8):1403-7. PubMed ID: 2665965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
    Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.